Variant report
Variant | esv3496394 |
---|---|
Chromosome Location | chr3:142609738-142610941 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:61)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:142609712-142609819 | HepG2 | liver: | n/a | chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739 |
2 | CEBPB | chr3:142609598-142609811 | K562 | blood: | n/a | chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739 |
3 | EBF1 | chr3:142610126-142610469 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr3:142609360-142609770 | SK-N-MC | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:142610864-142610914 | BJ | skin: | n/a |
2 | chr3:142610864-142610914 | PrEC | prostate: | n/a |
3 | chr3:142610864-142610914 | HRCEpiC | kidney: | n/a |
4 | chr3:142610864-142610914 | HMEC | breast: | n/a |
5 | chr3:142610864-142610914 | HIPEpiC | eye: | n/a |
6 | chr3:142610864-142610914 | SK-N-MC | brain: | n/a |
7 | chr3:142610864-142610914 | LNCaP | prostate: | n/a |
8 | chr3:142610864-142610914 | RPTEC | kidney: | n/a |
9 | chr3:142610864-142610914 | Hepatocyte | liver: | n/a |
10 | chr3:142610864-142610914 | ProgFib | skin: | n/a |
11 | chr3:142610864-142610914 | GM06990 | blood: | n/a |
12 | chr3:142610864-142610914 | GM12892 | blood: | n/a |
13 | chr3:142610864-142610914 | A549 | lung: | n/a |
14 | chr3:142610864-142610914 | Hela-S3 | cervix: | n/a |
15 | chr3:142610864-142610914 | HCF | heart: | n/a |
16 | chr3:142610864-142610914 | HEK293 | kidney: | embryo |
17 | chr3:142610864-142610914 | GM12891 | blood: | n/a |
18 | chr3:142610864-142610914 | MCF-7 | breast: | n/a |
19 | chr3:142610864-142610914 | IMR90 | lung: | fetal |
20 | chr3:142610864-142610914 | Caco-2 | colon: | n/a |
21 | chr3:142610864-142610914 | NHBE | bronchial: | n/a |
22 | chr3:142610864-142610914 | ECC-1 | luminal epithelium: | n/a |
23 | chr3:142610864-142610914 | Jurkat | blood: | n/a |
24 | chr3:142610864-142610914 | H1-hESC | embryonic stem cell: | embryo |
25 | chr3:142610864-142610914 | NH-A | brain: | n/a |
26 | chr3:142610864-142610914 | K562 | blood: | n/a |
27 | chr3:142610864-142610914 | U87 | brain: | n/a |
28 | chr3:142610864-142610914 | SK-N-SH_RA | brain: | n/a |
29 | chr3:142610864-142610914 | AG10803 | skin: | n/a |
30 | chr3:142610864-142610914 | HAEpiC | amniotic membrane: | n/a |
31 | chr3:142610864-142610914 | SK-N-SH | brain: | n/a |
32 | chr3:142610864-142610914 | T-47D | breast: | n/a |
33 | chr3:142610864-142610914 | HRE | kidney: | n/a |
34 | chr3:142610864-142610914 | ovcar-3 | ovarian: | n/a |
35 | chr3:142610864-142610914 | BE2_C | brain: | n/a |
36 | chr3:142610864-142610914 | SAEC | small airway: | n/a |
37 | chr3:142610864-142610914 | HL-60 | blood: | n/a |
38 | chr3:142610864-142610914 | HUVEC | blood vessel: | n/a |
39 | chr3:142610864-142610914 | AoSMC | blood vessel: | n/a |
40 | chr3:142610864-142610914 | CMK | blood: | n/a |
41 | chr3:142610864-142610914 | HCM | heart: | n/a |
42 | chr3:142610864-142610914 | HRPEpiC | eye: | n/a |
43 | chr3:142610864-142610914 | HPAEpiC | pulmonary alveolar: | n/a |
44 | chr3:142610864-142610914 | AG09309 | skin: | n/a |
45 | chr3:142610864-142610914 | NHDF-neo | bronchial: | n/a |
46 | chr3:142610864-142610914 | HCT-116 | colon: | n/a |
47 | chr3:142610864-142610914 | PANC-1 | pancreas: | n/a |
48 | chr3:142610864-142610914 | GM19239 | blood: | n/a |
49 | chr3:142610864-142610914 | SKMC | muscle: | n/a |
50 | chr3:142610864-142610914 | HCPEpiC | choroid plexus: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:142609483..142612071-chr3:142616369..142619084,2 | K562 | blood: | |
2 | chr3:142598080..142600621-chr3:142609257..142610987,2 | K562 | blood: | |
3 | chr3:142296468..142299283-chr3:142609997..142611852,2 | MCF-7 | breast: | |
4 | chr3:142606798..142610492-chr3:142610655..142614860,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PCOLCE2 | TF binding region |
PCOLCE2 | CpG island |
ENSG00000175054 | chromatin interactions |
ENSG00000163710 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139777863 | chr3:142609753-142609754 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs555136725 | chr3:142609759-142609760 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs3755734 | chr3:142609767-142609768 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs186220175 | chr3:142609807-142609808 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs144524042 | chr3:142609837-142609838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552982864 | chr3:142609858-142609859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4683434 | chr3:142609913-142609914 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs369020205 | chr3:142610044-142610045 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs571439630 | chr3:142610085-142610086 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs528238307 | chr3:142610118-142610119 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs546183182 | chr3:142610126-142610127 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs544977054 | chr3:142610157-142610158 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs563469896 | chr3:142610208-142610209 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs114723150 | chr3:142610239-142610240 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs190724503 | chr3:142610290-142610291 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs558474481 | chr3:142610293-142610294 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs532271340 | chr3:142610316-142610317 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs146656542 | chr3:142610356-142610357 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs528071402 | chr3:142610358-142610359 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs139096746 | chr3:142610361-142610362 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs149893665 | chr3:142610409-142610410 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs532816392 | chr3:142610412-142610413 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs551008265 | chr3:142610419-142610420 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs569420486 | chr3:142610423-142610424 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs112345129 | chr3:142610487-142610488 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs555099576 | chr3:142610522-142610523 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs567011673 | chr3:142610528-142610529 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs144968662 | chr3:142610543-142610544 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs6778966 | chr3:142610610-142610611 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs113748740 | chr3:142610643-142610644 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs149084292 | chr3:142610647-142610648 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs56237202 | chr3:142610663-142610664 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs56389497 | chr3:142610671-142610672 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs557007014 | chr3:142610684-142610685 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs575071355 | chr3:142610706-142610707 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs143144756 | chr3:142610726-142610727 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs373151539 | chr3:142610754-142610755 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs2707974 | chr3:142610797-142610798 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs182865641 | chr3:142610812-142610813 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs147846969 | chr3:142610843-142610844 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs73234726 | chr3:142610864-142610865 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs187932235 | chr3:142610865-142610866 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs191023424 | chr3:142610886-142610887 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs551235758 | chr3:142610898-142610899 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs73234727 | chr3:142610920-142610921 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530309510 | chr3:142610941-142610942 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 21129771 | CNVD |
Ovarian cancer | 23621864 | CNVD |
Breast cancer | 21364760 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:142608200-142610600 | Weak transcription | K562 | blood |
2 | chr3:142608400-142615200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:142608600-142615200 | Weak transcription | Hela-S3 | cervix |
4 | chr3:142608600-142615400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr3:142608600-142617800 | Weak transcription | Aorta | Aorta |
6 | chr3:142609200-142609800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr3:142609600-142613400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr3:142609600-142616800 | Weak transcription | Adipose Nuclei | Adipose |
9 | chr3:142609800-142610000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr3:142610000-142610200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:142610000-142615200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr3:142610400-142610600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr3:142610600-142611800 | Enhancers | K562 | blood |